Why Sharing Your Cancer Diagnosis Could Protect Your Family’s Health

We tend to treat a cancer diagnosis as deeply personal information. And emotionally, that’s fair. Clinically, it isn’t. It’s family risk data. And when that information is withheld, often out of kindness, it quietly removes someone else’s opportunity for earlier detection, better surveillance, and in some cases, prevention entirely.

Let’s use colorectal cancer (CRC) as the example, because it makes the point uncomfortably well.

Colorectal Cancer: The Case for Sharing Information

If a first-degree relative (parent, sibling, child) has been diagnosed with colorectal cancer:

• Risk increases approximately 2-fold

• Screening may need to start earlier

• Surveillance becomes more frequent
  

Guidelines in these individuals are clear:

• Begin screening at age 50 or

• Start 10 years earlier than the age at diagnosis of the affected relative
  

That second point is where things matter. A lot.

Because if no one knows when your family member was diagnosed, or even that they were diagnosed, there’s no adjustment. Just standard screening… for someone who isn’t actually standard risk.

Why Colonoscopy Matters More in Higher-Risk Patients

For individuals at increased risk, colonoscopy is preferred over stool-based FIT testing. Not because FIT is useless. It’s not. But colonoscopy does something FIT cannot … it removes precancerous polyps. Colorectal cancer is one of the few cancers where we can intervene before it exists. But only if we know who to look at more closely.

What Happens When Diagnoses Aren’t Shared

When this information stays quiet:

• Screening is delayed

• Risk is underestimated

• Prevention becomes less likely
  

This isn’t about alarming your family. It’s about giving them access to information that directly changes medical decision-making. If you’ve been diagnosed, the most useful thing you can tell your family is surprisingly simple:

• Type of cancer

• Age at diagnosis
  

That’s it. Two data points that can shift an entire screening timeline.

Symptoms of Colorectal Cancer (Worth Not Ignoring)

Most colorectal cancers don’t announce themselves dramatically. They tend to show up in ways that are easy to rationalize. Common symptoms:

• Rectal bleeding (especially blood mixed in stool)

• Abdominal pain or cramping

• Changes in bowel habits (constipation, diarrhea, narrow stools)

• Iron deficiency anemia

• Unintentional weight loss

• Fatigue
  

Less common, but more concerning:

• Abdominal distention, nausea, vomiting

• Melena (dark, tarry stools)

• Tenesmus (feeling of incomplete evacuation)

• Loss of appetite

If something here feels familiar, it’s worth investigating. And yes, advocate hard for yourself even if someone tells you you’re “too young.”

Screening Guidelines in Ontario

Average risk:

• Start at age 50

• Stool FIT test every 2 years until age 74

Increased risk (family history):

• Colonoscopy starting at age 50 or earlier (10 years before family diagnosis)

• If relative diagnosed before 60 → colonoscopy every 5 years

• If diagnosed after 60 → every 10 years

Meanwhile, American guidelines have already moved screening to age 45. The Canadian Cancer Society is pushing in the same direction because the epidemiology is changing.

Early-Onset Colorectal Cancer Is Increasing

This is the part people tend to underestimate. Rates of colorectal cancer are rising in younger populations:

• Significant increases in those under 40

• A 6.5-fold rise in ages 20–24 over two decades

• Now a leading cause of cancer-related death in men aged 20–49

So no, this is no longer just a “later in life” disease.

What About Celiac Disease?

Celiac disease often raises eyebrows in this conversation. Does it increase colorectal cancer risk? Short answer: not enough to change screening guidelines.

Major organizations (NCCN, USPSTF, AGA, ACG) do not classify celiac disease as an increased-risk condition for colorectal cancer. Patients follow standard screening recommendations. However, celiac disease is associated with other malignancies:

• Small intestinal adenocarcinoma

• Intestinal lymphoma

A Quick Note on Small Intestinal Cancers

These are less common, but worth recognizing because symptoms overlap and are often vague.

Small Intestinal Adenocarcinoma

• Abdominal pain

• Intestinal obstruction

• Weight loss

• Anemia / occult GI bleeding

• Palpable abdominal mass

• Jaundice

Intestinal Lymphoma

• Abdominal pain

• Weight loss

• Obstruction (less common)

• Perforation / acute abdomen

• Diarrhea / malabsorption

• Fever, night sweats

• Palpable abdominal mass

Not easy to distinguish clinically. Which is why you need to be aware of them.

Inflammatory Bowel Disease (IBD) Changes the Rules Entirely

If someone has ulcerative colitis or Crohn’s colitis, they are no longer “average risk.”

Per NCCN guidelines:

• Colonoscopy begins 8 years after symptom onset, regardless of age

• If primary sclerosing cholangitis (PSC) is present → annual colonoscopy immediately

Surveillance intervals:

• Low risk → every 2–5 years

• High risk → annually

• Dysplasia → tighter intervals depending on severity

Iron Deficiency: Not a Diagnosis

This is where things often go sideways in clinical practice. Iron deficiency gets treated like the problem. It isn’t. It’s a finding.

Prescribing iron without asking why someone is deficient is the medical equivalent of topping up a leaking tank and declaring victory. When ferritin is low, the real question is: Why?

Common contributors:

• Chronic blood loss (including gastrointestinal bleeding from colorectal cancer)

• Impaired absorption (low stomach acid, H. pylori, celiac disease)

• Inflammation (hepcidin-mediated iron sequestration) -> If someone is inflamed because they have a cancer, it’s better to test ferritin, iron, transferrin saturation AND an inflammatory marker like ESR and/or CRP. Inflammation will elevate ferritin, but not because your iron levels are good.

• Dietary factors

• Increased demand (pregnancy, endurance training)

• Medications (PPIs, antacids)
  

If you skip this step, you get a predictable cycle:

• Temporary improvement

• Relapse

• Occasionally… a missed diagnosis. Including colorectal cancer.

The Takeaway (The Part People Avoid)

We tend to look for complex solutions in medicine. Sometimes the highest-yield intervention is a conversation no one wants to have. Sharing a cancer diagnosis with your family is not about fear. It’s about giving them access to data that changes outcomes. Earlier screening. Better surveillance. Real prevention. It’s not glamorous or complicated, but clinically, it matters more than most things we spend time on.

• Dr.Brenda Tapp Leonard ND